2 - 4 February 2021
2nd Annual Biologics Manufacturing Japan 2021
Virtual
Join Biologics Manufacturing Japan 2021!
500+
Total Attendees
120+
Key Stakeholders
40+
Expert Speakers
20+
Total Networking Hours
The Concept
Home to the second-largest pharmaceutical market in the world, Japan has poised itself as one of the most lucrative biotech hubs in Asia, and worldwide. Over recent years, the Japanese biologics market has opened its doors to both foreign companies entering the Japanese market and companies investing abroad. Japan’s biopharma sector has had a keen eye on alliance opportunities in markets beyond its borders and although the nature of its sector is a cautious one, its move towards transparency and international collaboration provides bountiful opportunities that both the domestic and international players stand to benefit from.
The 2nd edition of the Biologics Manufacturing Japan 2021, aims to provide a neutral platform to address the challenges faced in this sector including high costs incurred in the downstream purification of highly complex molecules, purification process development to maximize process economy, difficulties in process development, scale-up and technology transfer for biologics, reduction of Cost-of-Goods for large-scale manufacturing, insights into the regulatory perspective on common pitfalls in analytical and CMC studies, Single-Use Systems in USP & DSP and Cost-Benefit analysis of CMO outsourcing strategies.
Join the conference to interact with key and upcoming entities from Japanese Biologics space include Chugai Pharmaceutical, Kyowa Hakko Kirin, UMN Pharma, Daiichi Sankyo, Daiichi Sankyo, Asahi Glass Co., Astellas Pharma and Fujifilm Holdings Corp among others.
Download Brochure
Biologics Manufacturing Japan will once again serve as the only bioprocessing focused platform in Japan for global partners and local stakeholders to leverage partnership opportunities, scientific innovation and manufacturing best practice case studies. This event will see the complete network of BIG Pharma, International Biopharma, Japanese Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities, Solution Providers and Technocrats under one roof. If Japan is the country you are looking at for plentiful opportunities in the bio-manufacturing space, then Biologics Manufacturing Japan 2021 is where you have to be!
Register Now!
2021 Speakers
To become a speaker yourself at the 2021 event, contact: Joey Park, Conference Producer, T: +65 3109 0124, E: joey.park@imapac.com
Jun Hu Wuxi Biologics
Director, Head of Japan BusinessWuxi BiologicsChina
Sushant Sahastrabuddhe International Vaccine Institute
DirectorInternational Vaccine InstituteSouth KoreaDr. Sushant Sahastrabuddhe (MBBS, MPH, MBA) is the Director of Enteric Fever program at the International Vaccine Institute in Seoul, South Korea. Sushant is working in IVI since last 7 years and is leading the typhoid conjugate vaccine development with multiple manufacturers. Sushant is a medical graduate from India with Masters in Public Health from Johns Hopkins Bloomberg School of Public Health, Baltimore, USA. Before joining IVI, Sushant was working with National AIDS Research Institute (NARI) under the umbrella of Indian Council of Medical Research (ICMR) for 4 years. He has been involved in many phase I/II trials, including that of HIV vaccines. During previous assignment at NARI, Sushant was also involved in monitoring of the HIV sentinel surveillance under National AIDS Control Organization (NACO) for the western states of India. Sushant has wide experience in conducting and managing clinical trials and major public health initiatives. Dr. Sahastrabuddhe has over 10 publications and 2 book chapters.
Nikolai Petrovsky Vaxine Pty Ltd
Chairman and Research DirectorVaxine Pty LtdAustralia
Dr. Raj Shankar Ghosh Bill and Melinda Gates Foundation
Deputy Director, Vaccine DeliveryBill and Melinda Gates Foundation IndiaRaj Shankar is a physician with 25 years of engagement in public health program policy, planning, implementation. Raj has worked in a large variety of organizations that ranged from small field level non-governmental organizations; State Health services; World Health Organization; international developmental partners such as PATH and Institute for OneWorld Health; and donor organization Bill & Melinda Gates Foundation. Some of the key positions that he held in his career are Block Medical Officer In-Charge, West Bengal Health Services; Surveillance Medical Officer; National Polio Surveillance Project (NPSP) of WHO - India; Regional Coordinator, South East Region, NPSP, WHO-India; Technical Director, Immunization, PATH-India; Director, Multi Country Japanese Encephalitis Project, South East Asia-Western Pacific Region, PATH; Regional Director, South Asia, Institute for OneWorld Health and Deputy Director, Vaccine Delivery and Infectious Diseases, Bill & Melinda Gates Foundation. Raj has led a team of clinical researchers to develop drugs for neglected diseases like Visceral Leishmaniasis in South Asia; has influenced policy decisions in new vaccine introduction in multiple countries in South Asia and spearheaded public health program planning and implementation in India and Nepal. His current focus is primarily in advocacy for evidence based policies and capacity building of public health institutions in India.Raj Shankar has multiple publications and has authored chapters on vaccines in books for pediatricians. He was awarded the prestigious Fellowship of Indian Public Health Association in 2014.
Harkabir Jandu Clinton Health Access Initiative
Director, ImmunizationClinton Health Access InitiativeIndia
Andrew Wong Shanghai Zerun Biotechnology
Vice PresidentShanghai Zerun BiotechnologyChina
Pierre A. Morgon Eurocine Vaccines, NED, Vaccitech, NED, Univercells
CEO | Chairman | Non Executive Director | Mentor | AdvisorEurocine Vaccines, NED, Vaccitech, NED, Univercells
Dinesh Khokal Amgen
Director, External Affairs, Corporate Quality, Japan Asia Pacific & IntercontinentalAmgenSingapore
Prof Maria Elena Bottazzi Baylor College of Medicine
Associate DeanBaylor College of MedicineUSA
Hiroyuki Moriuchi Nagasaki University Graduate School of Biomedical Sciences & School of Tropical Medicine and Global Health
Professor and Head, Department of PediatricsNagasaki University Graduate School of Biomedical Sciences & School of Tropical Medicine and Global HealthJapan
Dr. Asel Sartbaeva University of Bath
LecturerUniversity of BathUnited Kingdom
Dr. Zoltán Kis Imperial College London
Research Associate, Future Vaccines Manufacturing Hub at the Centre for Process Systems Engineering, Department of Chemical EngineeringImperial College LondonUnited Kingdom
Uwe Voelker Roche
Site Head, Drug Product ManufacturingRocheGermany
Yong Jick Kim Polus Inc.
Senior Vice Chairman and Chief Technology OfficerPolus Inc.South KoreaDr. Yong Jick Kim is currently the Senior Vice Chairman and CTO of Polus Inc., Korea. Prior to his appointment, he worked as COO and SVP of Manufacturing Operations at Celltrion Inc., Korea. Yong has developed key expertise in Large Scale Manufacturing Operations, Validation, Project Management and Research & Development with 25 years of progress responsibilities in Biopharmaceutical industry. He has demonstrated high level performance in Technology Transfer, Facility/Equipment Design, Process Development/Optimization, CMC as well as New Business Development.
Shuichi Yamamoto Yamaguchi University Biomedical Engineering Center
DirectorYamaguchi University Biomedical Engineering CenterJapanHe received a BS degree in 1976, a MS in 1978 and a Ph. D in 1981 in the department of Food Science and technology at Kyoto University. He has been at Yamaguchi University since 1981 (Assistant Professor 1981-1988, Associate Professor 1989-1997, Professor 1998-present).
He teaches basic chemical engineering, biochemical engineering, separation engineering, transport phenomena, computer calculations for chemical engineering and process design.
His research interests are in the field of biochemical engineering, food engineering and mass transfer.
He received a 2004 research excellence award from the Society of Chemical Engineers Japan on “Engineering analysis of chromatography of proteins” and a 2005 research excellence award from Japan Society for Food Engineering on “Drying of liquid foods and inactivation of enzymes during drying”.
The following paper has been recognized in the “Top-75 most cited articles” as published in the IChemE journals 2006 – 2009. Shuichi Yamamoto and Ayako Kita, Rational design calculation method for stepwise elution chromatography of proteins, Trans.IChemE.Part C., Food and Bioproducts Processsing, Vol.84, C1, 72-77,2006
He has published more than 100 scientific papers. Among them, his monograph published in 1988 by Marcel Dekker “Ion-Exchange Chromatography of Proteins” is well-known. His chromatography model better known as “Yamamoto Model” and “Yamamoto number” has been employed by various biotech companies as well as by academic researchers. It is partly explained in Perry’s Chemical Engineering Handbook (pp.16-44, 16-45). A text book “Bioseparations Science and Engineering” by R.G.Harris et al. (Oxford press, 2003) describes in detail how to use his model with a Yamamoto number. His diffusion-based drying model is also called “Yamamoto model” as well, and has been used by many researchers.
He is a sub project leader of the National research project (Manufacturing Technology Association of Biologics).
He has also published several text books (chapters) for drying, mass transfer and adsorptions. He has been organizing a course “Basic Chemical Engineering“, for those who are working at chemical industries.
Currently he is Vice President of Asian Pacific Confederation of Chemical Engineers (APCChE) and a board member of World Chemical Engineering Council (WCEC) as a representative of the Society of Chemical Engineers, Japan (SCEJ).
He also serves as an editorial board member for the following journals; Separation Science and Technology, Preparative Biochemistry and Biotechnology, BioProcess International, Japan Journal of Food Engineering (Chief Editor).
For his university, he serves as the vice director of the university library and the director of Biomedical Engineering Center (YUBEC).
Yoshikazu Honda-Okubo Vaxine
Senior Research ScientistVaxineAustralia
2021 Sponsors & Exhibitors
Become A Sponsor
Biologics Manufacturing Japan will provide commercial organizations with the opportunity to educate the market by raising brand awareness and positioning yourselves as leaders in the field. By maximizing face time with key profiles from biologics manufacturers from the region regulators and national health organizations all in a single location, you will enjoy the option of privately arranged meetings and consultations with selected potential clients.
Market Intelligence
eBook: Japan's Biomanufacturing Landscape 2021
eBook: Attendee List for Biologics Manufacturing Japan 2019
eBook: Expert Opinions on Japan's Bio-Manufacturing Successes.
eBook: Japan's Production Capabilities
eBook: Partnerships in Japanese Biopharma Industry
Join Biologics Manufacturing Japan 2021!
Sponsorship Opportunities
Charmaine Poh
Business Development Manager
Email: charmaine.poh@imapac.com
English 
简体中文 
日本語 
한국어 
繁體中文